Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Revisão |
| 語言: | 英语 |
| 出版: |
2020
|
| 在線閱讀: | https://doi.org/10.1080/14737159.2020.1768849 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!